Effectiveness of Laying-on-of-hands for Sickle Cell Disease
Launched by MOA HEALTH SCIENCE FOUNDATION · Jan 21, 2012
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
Patients with sickle cell disease (SCD) have a high risk of premature death in Africa, mainly due to insufficient medical services. SCD patients often visit emergency department and need hospitalization when they suffer from severe pain; however, they manage most of painful episodes at home. Appropriate pain management at home is, therefore, crucial to improve their clinical course and quality of life. Laying-on-of-hands may be a good candidate for home care management, because family member(s) can become a practitioner of laying-on-of-hands without difficulty and administer it to their lov...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with symptoms associated with sickle cell disease
- • those able to receive laying-on-of-hands every weekday for 1 year
- • those able to receive conventional medical treatment whenever necessary
- • those able to receive blood test at the beginning, after 6 month and after 1 year
- Exclusion Criteria:
- • those who wish to use other complementary and alternative therapies along with laying-on-of-hands
About Moa Health Science Foundation
Moa Health Science Foundation is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on collaboration and scientific rigor, the foundation supports a variety of clinical studies aimed at addressing unmet medical needs across multiple therapeutic areas. By leveraging a network of experienced researchers and healthcare professionals, Moa Health Science Foundation strives to facilitate the development of safe and effective treatments that enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kinshasa, , Congo, The Democratic Republic Of The
Patients applied
Trial Officials
Kodondi K Koto, MD, PhD
Study Director
The Institute of Scientific Research for Health, Kinshasa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials